Management of Drug Interactions with Inducers: Onset and Disappearance of Induction on Cytochrome P450 3A4 and Uridine Diphosphate Glucuronosyltransferase 1A1 Substrates. [PDF]
Bettonte S +4 more
europepmc +1 more source
In Vitro Pharmacokinetic Properties of MK-2048, a Potent Drug Candidate for HIV Prevention. [PDF]
Zheng R +5 more
europepmc +1 more source
Implementation and Uptake of Raltegravir Granules in Newborns Diagnosed With HIV Through Birth Testing in Maternity Settings in Zimbabwe During the COVID-19 Pandemic. [PDF]
Denoeud-Ndam L +13 more
europepmc +1 more source
Association of HLA-B*53 With DRESS Syndrome in Patients Treated With Raltegravir: Two Case Reports and a Literature Review. [PDF]
Ramos-Del Moral C +10 more
europepmc +1 more source
Association between plasma concentrations of integrase strand transfer inhibitors and body weight gain in women with HIV. [PDF]
Lahiri CD +22 more
europepmc +1 more source
Influence of concurrent oral calcium carbonate supplementation on steady-state pharmacokinetics of once daily oral raltegravir in persons with HIV: a protocol for a prospective open-label non-randomised study in Canada. [PDF]
Teixeira Nunes Porto LL +6 more
europepmc +1 more source
The protective role of raltegravir in experimental acute lung injury in vitro and in vivo. [PDF]
Xu Z, Ren R, Jiang W.
europepmc +1 more source
Efficacy of raltegravir in achieving virological suppression at delivery in HIV-positive pregnant women: a systematic review and meta-analysis. [PDF]
Zhang Y +5 more
europepmc +1 more source
Mapping the Gut Microbiota Composition in the Context of Raltegravir, Dolutegravir, and Bictegravir-A Scoping Review. [PDF]
Gáspár Z, Lakatos B.
europepmc +1 more source
Human iPSC-derived neurons reveal NMDAR-independent dysfunction following HIV-associated insults. [PDF]
Starr A +4 more
europepmc +1 more source

